CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes Lifestyle Modifications for Preventing and Treating Heart Failure When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney disease Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure

Original Research2020 Jul 18.

JOURNAL:ESC Heart Fail. Article Link

Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure

HC Chang, CJ Huang, HM Cheng et al. Keywords: acute heart failure; nighttime haemodynamics; nocturnal thoracic volume overload; post-discharge outcomes

Full Text PDF